Funding opportunities
713 live opportunities from Grants.gov, NIH, NSF, and more.
Biology & Life Sciences× remove
- Immune-checkpoint engineered islets as beta cell replacement therapy for type I diabetesNational Institute of Diabetes and Digestive and Kidney DiseasesPA-25-301 closes 4/30/2030up to $799,693activenih
- Illuminating the secretome: a protein tagging resourceNIH Office of the DirectorRFA-OD-22-013 closes 4/30/2030up to $790,502activenih
- Delineating the impact of beige adipocytes in the metabolismNational Institute of Diabetes and Digestive and Kidney DiseasesPA-25-301 closes 4/30/2030up to $771,701activenih
- A CRISPR-based sensitive liquid biopsy for endometrial cancer using tumor-derived hallmarks (CRISPR SLEUTH)National Cancer InstitutePAR-25-336 closes 4/30/2030up to $650,513activenih
- Regulation of Insulin Sensitivity by a Novel AdipokineNational Institute of Diabetes and Digestive and Kidney DiseasesPA-25-301 closes 4/30/2030up to $794,101activenih
- Understanding the Role of the X Chromosome in COPD through Integrated Multi-Omic ApproachesNational Heart Lung and Blood InstitutePA-24-176 closes 4/30/2030up to $177,355activenih
- Computational Model-Driven Design of Organ Scale Vasculature for Biomanufactured TissuesNational Heart Lung and Blood InstitutePA-25-301 closes 3/31/2030up to $767,249activenih
- Deeply subwavelength near infrared imaging with avalanching nanoparticlesNational Institute of General Medical SciencesPAR-25-203 closes 3/31/2030up to $430,109activenih
- Live-cell functions of histone PTM readers and histone H2A.Z variant in epigenetic regulation of transcriptionNational Institute of General Medical SciencesPA-25-301 closes 3/31/2030up to $326,463activenih
- Selective autophagy mediated by TRIM proteinsNational Institute of General Medical SciencesPA-25-301 closes 3/31/2030up to $517,014activenih
- Novel biomarkers of kidney disease in type 1 diabetesNational Institute of Diabetes and Digestive and Kidney DiseasesPA-25-301 closes 3/31/2030up to $812,862activenih
- Characterizing glycosylation regulatory networks using single-cell multiomics and mathematical modelingNational Institute of General Medical SciencesPA-25-301 closes 3/31/2030up to $343,007activenih
- Methadone dose-associated risks and outcomes in opioid use disorder treatmentNational Institute on Drug AbusePA-25-301 closes 3/31/2030up to $641,138activenih
- Understanding Mammalian Golgi Trafficking MechanismsNational Institute of General Medical SciencesPA-25-301 closes 3/31/2030up to $605,140activenih
- A novel circuit in BCAA catabolism that affects cardiometabolic disease phenotypesNational Institute of Diabetes and Digestive and Kidney DiseasesPA-25-301 closes 3/31/2030up to $821,373activenih
- Copper at Host-Pathogen Interface During Urinary Tract InfectionNational Institute of Diabetes and Digestive and Kidney DiseasesPA-25-301 closes 3/31/2030up to $364,769activenih
- The role of ADAMTS13 in Pathogenesis of PreeclampsiaNational Heart Lung and Blood InstitutePA-25-301 closes 3/31/2030up to $556,103activenih
- Medullary Control of REM SleepNational Heart Lung and Blood InstitutePA-25-301 closes 2/28/2030up to $551,052activenih
- Defining the Multi-Omics Landscape of Phospholamban-induced Cardiomyopathy for Precision MedicineNational Heart Lung and Blood InstitutePA-25-301 closes 2/28/2030up to $747,262activenih
- Application of integrative omics to identify mechanistic pathways of adverse outcomes in children with chronic kidney diseaseNational Institute of Diabetes and Digestive and Kidney DiseasesPA-25-301 closes 2/28/2030up to $934,242activenih
- The Pyruvate-Lactate Metabolic Axis in Heart Failure and RecoveryNational Heart Lung and Blood InstitutePA-25-301 closes 2/28/2030up to $635,681activenih
- New Methods to Generate High-Performance Aptamers for in Vivo Monitoring of Small MoleculesNational Institute of Biomedical Imaging and BioengineeringPA-25-301 closes 2/28/2030up to $691,316activenih
- Targeting lipolytic sterol signaling to foster favorable foam cell modulation and atheroprotection.National Heart Lung and Blood InstitutePA-25-301 closes 2/28/2030up to $586,474activenih
- Developing Novel High-dimensional Integrative Mediation Analysis Methods and Tools for Cardiovascular DiseasesNational Heart Lung and Blood InstitutePA-25-301 closes 2/28/2030up to $657,595activenih
- Enteroendocrine cell reprogramming in metabolic diseaseNational Institute of Diabetes and Digestive and Kidney DiseasesPA-25-301 closes 2/28/2030up to $735,358activenih